These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 17314403)

  • 21. Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia J; Marchese E; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Jun; 14(3):370-384. PubMed ID: 29546607
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro assay for the efficacy assessment of AAV vectors expressing microdystrophin.
    Danilov KA; Vassilieva SG; Polikarpova AV; Starikova AV; Shmidt AA; Galkin II; Tsitrina AA; Egorova TV; Orlov SN; Kotelevtsev YV
    Exp Cell Res; 2020 Jul; 392(2):112033. PubMed ID: 32360435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA.
    Liu F; Nishikawa M; Clemens PR; Huang L
    Mol Ther; 2001 Jul; 4(1):45-51. PubMed ID: 11472105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
    He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
    Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
    Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
    Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
    Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
    Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Restoration of human dystrophin following transplantation of exon-skipping-engineered DMD patient stem cells into dystrophic mice.
    Benchaouir R; Meregalli M; Farini A; D'Antona G; Belicchi M; Goyenvalle A; Battistelli M; Bresolin N; Bottinelli R; Garcia L; Torrente Y
    Cell Stem Cell; 2007 Dec; 1(6):646-57. PubMed ID: 18371406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cells derived from human induced pluripotent stem cells improve the engraftment of myogenic cells by secreting urokinase-type plasminogen activator receptor (uPAR).
    Elhussieny A; Nogami K; Sakai-Takemura F; Maruyama Y; Takemura N; Soliman WT; Takeda S; Miyagoe-Suzuki Y
    Stem Cell Res Ther; 2021 Oct; 12(1):532. PubMed ID: 34627382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vivo and in vitro correction of the mdx dystrophin gene nonsense mutation by short-fragment homologous replacement.
    Kapsa R; Quigley A; Lynch GS; Steeper K; Kornberg AJ; Gregorevic P; Austin L; Byrne E
    Hum Gene Ther; 2001 Apr; 12(6):629-42. PubMed ID: 11426463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracorporeal circulation as a new experimental pathway for myoblast implantation in mdx mice.
    Torrente Y; D'Angelo MG; Del Bo R; DeLiso A; Casati R; Benti R; Corti S; Comi GP; Gerundini P; Anichini A; Scarlato G; Bresolin N
    Cell Transplant; 1999; 8(3):247-58. PubMed ID: 10442737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy.
    Siemionow M; Cwykiel J; Heydemann A; Garcia-Martinez J; Siemionow K; Szilagyi E
    Stem Cell Rev Rep; 2018 Apr; 14(2):189-199. PubMed ID: 29305755
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic correction of dystrophin deficiency and skeletal muscle remodeling in adult MDX mouse via transplantation of retroviral producer cells.
    Fassati A; Wells DJ; Sgro Serpente PA; Walsh FS; Brown SC; Strong PN; Dickson G
    J Clin Invest; 1997 Aug; 100(3):620-8. PubMed ID: 9239410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of CCAAT/Enhancer-Binding Protein β Expression With the Phosphodiesterase Inhibitor Isobutylmethylxanthine Improves Myoblast Engraftment Into Dystrophic Muscle.
    Lala-Tabbert N; Fu D; Wiper-Bergeron N
    Stem Cells Transl Med; 2016 Apr; 5(4):500-10. PubMed ID: 26941360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repression of phosphatidylinositol transfer protein α ameliorates the pathology of Duchenne muscular dystrophy.
    Vieira NM; Spinazzola JM; Alexander MS; Moreira YB; Kawahara G; Gibbs DE; Mead LC; Verjovski-Almeida S; Zatz M; Kunkel LM
    Proc Natl Acad Sci U S A; 2017 Jun; 114(23):6080-6085. PubMed ID: 28533404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophy.
    Rodino-Klapac LR; Janssen PM; Montgomery CL; Coley BD; Chicoine LG; Clark KR; Mendell JR
    J Transl Med; 2007 Sep; 5():45. PubMed ID: 17892583
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Blocking the myostatin signal with a dominant negative receptor improves the success of human myoblast transplantation in dystrophic mice.
    Fakhfakh R; Michaud A; Tremblay JP
    Mol Ther; 2011 Jan; 19(1):204-10. PubMed ID: 20700111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MyD88 is required for satellite cell-mediated myofiber regeneration in dystrophin-deficient mdx mice.
    Gallot YS; Straughn AR; Bohnert KR; Xiong G; Hindi SM; Kumar A
    Hum Mol Genet; 2018 Oct; 27(19):3449-3463. PubMed ID: 30010933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice.
    Su X; Shen Y; Jin Y; Jiang M; Weintraub N; Tang Y
    J Vis Exp; 2019 Apr; (146):. PubMed ID: 31033952
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Herpes simplex virus vector-mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle.
    Akkaraju GR; Huard J; Hoffman EP; Goins WF; Pruchnic R; Watkins SC; Cohen JB; Glorioso JC
    J Gene Med; 1999; 1(4):280-9. PubMed ID: 10738561
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Codon optimization of the microdystrophin gene for Duchene muscular dystrophy gene therapy.
    Athanasopoulos T; Foster H; Foster K; Dickson G
    Methods Mol Biol; 2011; 709():21-37. PubMed ID: 21194019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.